Overview

the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human

Status:
RECRUITING
Trial end date:
2024-12-10
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. The aim of the trial is to investigate safety, tolerability, and pharmacokinetics of the Mulberry Twig Alkaloids tablets (WH006) in healthy ,overweight and obesity subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Beijing Wehand-Bio Pharmaceutical Co., Ltd
Collaborator:
Peking University First Hospital